AI assistant
CLOROX CO /DE/ — Director's Dealing 2004
Aug 16, 2004
30403_dirs_2004-08-16_0235f9d5-08e0-4815-9867-8ae1aa94983d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2004-06-30
Reporting Person: MATSCHULLAT ROBERT W (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2003-08-15 | Deferred Stock Units | $0.00 | J | 39.03 | Acquired | Common Stock (39.03) | Direct | |
| 2003-09-30 | Deferred Stock Units | $0.00 | A | 599.52 | Acquired | Common Stock (599.52) | Direct | |
| 2003-11-14 | Deferred Stock Units | $0.00 | J | 38.92 | Acquired | Common Stock (38.92) | Direct | |
| 2003-12-31 | Deferred Stock Units | $0.00 | A | 257.41 | Acquired | Common Stock (257.41) | Direct | |
| 2003-12-31 | Deferred Stock Units | $0.00 | A | 208.9 | Acquired | Common Stock (208.90) | Direct | |
| 2004-02-13 | Deferred Stock Units | $0.00 | J | 40.82 | Acquired | Common Stock (40.82) | Direct | |
| 2004-03-31 | Deferred Stock Units | $0.00 | A | 1277.86 | Acquired | Common Stock (1277.86) | Direct | |
| 2004-05-14 | Deferred Stock Units | $0.00 | J | 45.96 | Acquired | Common Stock (45.96) | Direct | |
| 2004-06-30 | Deferred Stock Units | $0.00 | A | 1162.14 | Acquired | Common Stock (1162.14) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2648.00 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) - 03AT | $42.65 | 2013-07-01 | Common Stock (3000.00) | 3000.00 | Direct |
Footnotes
F1: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Stock-Based Compensation Plan.
F2: The Deferred Stock Units accrued pursuant to the Independent Directors' Stock-Based Compensation Plan will be settled 100% in Clorox stock upon the reporting person's retirement or other termination of service as a Director.
F3: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fee pursuant to the Independent Directors' stock-Based Compensation Plan.
F4: Annual $10,000 award of Deferred Stock Units pursuant to the Independent Directors' Compensation Plan.
F5: Option exercisable in 3 equal installments - 1/3 on each of the first, second and third anniversaries of the grant date.